Back to ActusNews

OCTOPUS BIOSAFETY

ISIN: FR0013310281

WKN: A2JGS9

About

Company Snapshot

New: Enable Investor Alerts

Be informed about new publications

New: AI Factsheet

Corporate News meets AI!
Content analysis and summary

Octopus Biosafety · ISIN: FR0013310281 · ActusNews (ID: 89146)

15 December 2024 08:00AM

OCTOPUS BIOSAFETY : MISE A DISPOSITION DES DOCUMENTS DE L'ASSEMBLEE GÉNÉRALE DU 30 DECEMBRE 2024

AURAY, le 15 decembre 2024 : Octopus Biosafety (Euronext Access Paris FR0013310281, MLOCT) annonce la mise à disposition des documents relatifs à l'assemblée générale mixte du 30 décembre 2024.

Les documents sont consultables sur la page documentation financière.

https://www.octopusbiosafety.com/documentations-financieres/

Les actions de la société Octopus Biosafety S.A. sont cotées sur Euronext Access Paris (code ISIN FR0013310281 - Mnémonique : MLOCT).

Plus d'informations sur :

www.octopusbiosafety.com

Cette publication dispose du service " 🔒 Actusnews SECURITY MASTER ".
- SECURITY MASTER Key : m2ublJ2XaGuXmZtqZZZrb5KXb2ZklGKdZmHJmWqclZjHaW5nm2+SbJbGZnFqlmls
- Pour contrôler cette clé : https://www.security-master-key.com.

Information réglementée :
Communiqués de mise à disposition de documents :
- Modalités de mise à disposition des documents préparatoires à l'AG

Communiqué intégral et original au format PDF : https://www.actusnews.com/news/89146-cp_ob_15122024.pdf

© Copyright Actusnews Wire
Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com

This publication was provided by our content partner ActusNews

Actusnews Wire

via

News Distribution Services

Contact:

Cordonnerie Du Sème, 52 Rue de Ponthieu, 75008 Paris, France

+33 1 53 67 35 70

Website

Twitter
Meta
Youtube
Instagram
LinkedIn
Contact
Newsfeed
RSS
Blog

Result of the AI analysis...

Tip: Registered users of the community can save the snippets in the user account.

Disclaimer:

This summary was created with the help of an AI technology. The goal is to bring out the core message of the company's message. The simplification of the statement can help to grasp the content of the message more quickly. The feature is experimental in nature. Do not use the information without verification. More information about Lab features can be found here.

Caution: Unverified adoption of previously unquality-assured information is not advised.

First Name *

Last Name

Email *

Subject *

i.e Feature x is not working

Issue happened on *

This page

Other page

Bug Detail *

Please give us more detailed explanation of the issue

Steps to reproduce *

Specify the steps you've done before the issue happen

Actual Result *

What's the result of the issue?

Expected Result *

What do you expect to see?

Attachment

(Optional) You can send us a screenshot, word document, or a PDF explaining the issue

Please log in to your user account. This will allow us to contact you in case of any queries.

I would like to remain anonymous.

OCTOPUS BIOSAFETY : MISE A DISPOSITION DES DOCUMENTS DE L'ASSEMBLEE GÉNÉRALE DU 30 DECEMBRE 2024

Newsletter